Tuesday, March 8, 2016

InVivo Therapeutics Holdings (NVIV) Surged On Study Results

InVivo Therapeutics Holdings (NVIV) announced Monday morning that the fifth patient treated with its Neuro-Spinal Scaffold has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury six months post implant.

from RTT - Before the Bell http://ift.tt/21iZKsC
via IFTTT

No comments:

Post a Comment